Thalidomide‐induced teratogenesis: History and mechanisms
Тератогенез, индуцированный талидомидом: история и механизмы
2015-06-01
SCID: 54.1/gz5cb8gr
Discuss with AI
embryonic malformationsleprosy complicationsmolecular mechanismsmultiple myelomathalidomide-induced teratogenesis
Figures from the paper
Abstract (AI)
Nearly 60 years ago thalidomide was prescribed to treat morning sickness in pregnant women. What followed was the biggest man-made medical disaster ever, where over 10,000 children were born with a range of severe and debilitating malformations. Despite this, the drug is now used successfully to treat a range of adult conditions, including multiple myeloma and complications of leprosy. Tragically, a new generation of thalidomide damaged children has been identified in Brazil. Yet, how thalidomide caused its devastating effects in the forming embryo remains unclear. However, studies in the past few years have greatly enhanced our understanding of the molecular mechanisms the drug. This review will look at the history of the drug, and the range and type of damage the drug caused, and outline the mechanisms of action the drug uses including recent molecular advances and new findings. Some of the remaining challenges facing thalidomide biologists are also discussed.
Key Findings
1
A new generation of children affected by thalidomide exposure has been identified in Brazil.
2
Despite its teratogenic history, thalidomide is currently used therapeutically for multiple myeloma and complications of leprosy.
3
Recent studies have substantially advanced understanding of thalidomide’s molecular mechanisms, although how it disrupts embryonic development remains incompletely resolved.
4
Thalidomide caused over 10,000 cases of severe congenital malformations after being prescribed for morning sickness during pregnancy.
5
The review synthesizes thalidomide’s history, injury patterns, mechanisms of action, recent molecular findings, and remaining research challenges.
Research Object
thalidomide-exposed forming embryos
Research Subject
the teratogenic damage and molecular mechanisms of thalidomide-induced embryonic malformations
Publication Details
Publication Date
2015-06-01
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest